BioGaia AB (publ) (STO:BIOG.B)
Sweden · Delayed Price · Currency is SEK 108.40
-3.30 (-2.95%)
At close: Mar 2, 2026
BioGaia AB Market Cap
BioGaia AB has a market cap or net worth of 10.97 billion as of March 2, 2026. Its market cap has decreased by -16.23% in one year.
Market Cap
10.97B
Enterprise Value
10.16B
Revenue
1.54B
Ranking
n/a
PE Ratio
32.95
Stock Price
108.40
Market Cap Chart
Since December 31, 1998, BioGaia AB's market cap has increased from 181.00M to 10.97B, an increase of 5,958.49%. That is a compound annual growth rate of 16.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 11.30B | 5.18% |
| Dec 30, 2025 | 10.74B | -5.09% |
| Dec 30, 2024 | 11.32B | 10.77% |
| Dec 29, 2023 | 10.22B | 21.10% |
| Dec 30, 2022 | 8.44B | -19.33% |
| Dec 30, 2021 | 10.46B | -3.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 136.67B |
| Cereno Scientific AB | 1.98B |
| EQL Pharma AB | 1.71B |
| Orexo AB | 990.58M |
| Cinclus Pharma Holding AB | 811.62M |
| Nanexa AB | 655.87M |
| Dicot Pharma AB | 599.79M |
| Moberg Pharma AB | 486.46M |